The
DNA and RNA sample preparation market involves processes and techniques that
are required for isolating and purifying nucleic acids from biological samples
for further analysis. DNA and RNA sample preparation kits are used to extract
and purify DNA and RNA samples from blood, tissues, cells, and other specimens.
These kits contain buffers, reagents, and consumables required for isolating
and purifying nucleic acids using manual or automated protocols. The extracted
DNA and RNA samples can then be used for various downstream applications such
as next-generation sequencing, polymerase chain reaction, microarrays, and
other molecular diagnostic techniques.
The
Global DNA and RNA Sample Preparation Market is estimated to be valued at US$
2262.46 Mn in 2024 and is expected to exhibit a CAGR of 5.8% over the forecast
period 2024 to 2031.
Key Takeaways
Key players operating in the DNA and RNA sample preparation market are Agilent
Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc.,
DiaSorin S.p.A, F. Hoffmann-La Roche, Miroculus, Inc., Illumina, Inc., PerkinElmer,
Inc., QIAGEN, Sigma Aldrich Corp., Tecan Group AG, and Thermo Fisher
Scientific, Inc. The rising incidence of infectious diseases, genetic
disorders, and cancers is fueling the demand for personalized medicine and
precision diagnostics. This is driving the demand for DNA and RNA sample
preparation products.
Advancements in sample preparation techniques are enabling greater nucleic acid
yields from smaller sample volumes. Growing investments by pharmaceutical and
biotech companies in genomic research and clinical testing are further
supporting the expansion of the
DNA
and RNA Sample Preparation Market Size globally. Key industry players
are focusing on developing integrated, automated sample preparation solutions
to streamline workflows and reduce turnaround times.
Market key trends
One of the key trends gaining traction in the DNA and RNA sample preparation
market is automation and integration. Fully automated, high-throughput sample
preparation platforms are being developed to increase productivity and
throughput. Automated solutions minimize manual errors, save labor costs and
consumables, and boost overall workflow efficiency compared to manual methods.
Companies are also focusing on platform integration, offering complete
end-to-end sample preparation and analysis solutions from sample to result.
This simplifies workflows and provides seamless sample processing with better
consistency and reproducibility.
Porter's Analysis
Threat of new entrants: Low capital requirements for automation as technology
gets commoditized raises risk.
Bargaining
power of buyers: Large pharma and biotech companies can negotiate better prices
exerting pressure on pricing.
Bargaining
power of suppliers: Presence of alternative reagent and kits suppliers restrict
monopolistic practices.
Threat
of new substitutes: Bioinformatics tools for interpretation of NGS data poses
risk.
Competitive
rivalry: Intensifying competition to improve workflow efficiency and expand
product portfolios.
The North American region accounted for the highest value share in the DNA and
RNA sample preparation market in 2024. Factors such as presence of advanced
healthcare and research infrastructure coupled with huge investments in
genomics and NGS technologies drive the market in the region.
The Asia Pacific region is poised to witness the fastest growth over the
forecast period in the DNA and RNA sample preparation market. This is attributed
to expanding research base, increasing healthcare expenditure, growing focus on
precision medicine, and modernization of diagnostic labs in several APAC
countries including China, India and South Korea.
Also read related article on Surgical
Robots Market
Discover the Report for More Insights, Tailored to
Your Language
French
German
Italian
Russian
Japanese
Chinese
Korean
Portuguese
Comments
Post a Comment